Cargando…
Correction: Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061288/ https://www.ncbi.nlm.nih.gov/pubmed/35414658 http://dx.doi.org/10.1038/s41375-022-01567-4 |
| _version_ | 1784698698235641856 |
|---|---|
| author | Abdallah, Nadine Murray, David Dispenzieri, Angela Kapoor, Prashant Gertz, Morie A. Lacy, Martha Q. Hayman, Suzanne R. Buadi, Francis K. Gonsalves, Wilson Muchtar, Eli Leung, Nelson Dingli, David Kourelis, Taxiarchis Warsame, Rahma Binder, Moritz Kyle, Robert A. Rajkumar, S. Vincent Kumar, Shaji |
| author_facet | Abdallah, Nadine Murray, David Dispenzieri, Angela Kapoor, Prashant Gertz, Morie A. Lacy, Martha Q. Hayman, Suzanne R. Buadi, Francis K. Gonsalves, Wilson Muchtar, Eli Leung, Nelson Dingli, David Kourelis, Taxiarchis Warsame, Rahma Binder, Moritz Kyle, Robert A. Rajkumar, S. Vincent Kumar, Shaji |
| author_sort | Abdallah, Nadine |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9061288 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90612882022-05-04 Correction: Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab Abdallah, Nadine Murray, David Dispenzieri, Angela Kapoor, Prashant Gertz, Morie A. Lacy, Martha Q. Hayman, Suzanne R. Buadi, Francis K. Gonsalves, Wilson Muchtar, Eli Leung, Nelson Dingli, David Kourelis, Taxiarchis Warsame, Rahma Binder, Moritz Kyle, Robert A. Rajkumar, S. Vincent Kumar, Shaji Leukemia Correction Nature Publishing Group UK 2022-04-12 2022 /pmc/articles/PMC9061288/ /pubmed/35414658 http://dx.doi.org/10.1038/s41375-022-01567-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Abdallah, Nadine Murray, David Dispenzieri, Angela Kapoor, Prashant Gertz, Morie A. Lacy, Martha Q. Hayman, Suzanne R. Buadi, Francis K. Gonsalves, Wilson Muchtar, Eli Leung, Nelson Dingli, David Kourelis, Taxiarchis Warsame, Rahma Binder, Moritz Kyle, Robert A. Rajkumar, S. Vincent Kumar, Shaji Correction: Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab |
| title | Correction: Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab |
| title_full | Correction: Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab |
| title_fullStr | Correction: Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab |
| title_full_unstemmed | Correction: Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab |
| title_short | Correction: Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab |
| title_sort | correction: tracking daratumumab clearance using mass spectrometry: implications on m protein monitoring and reusing daratumumab |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061288/ https://www.ncbi.nlm.nih.gov/pubmed/35414658 http://dx.doi.org/10.1038/s41375-022-01567-4 |
| work_keys_str_mv | AT abdallahnadine correctiontrackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT murraydavid correctiontrackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT dispenzieriangela correctiontrackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT kapoorprashant correctiontrackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT gertzmoriea correctiontrackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT lacymarthaq correctiontrackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT haymansuzanner correctiontrackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT buadifrancisk correctiontrackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT gonsalveswilson correctiontrackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT muchtareli correctiontrackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT leungnelson correctiontrackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT dinglidavid correctiontrackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT kourelistaxiarchis correctiontrackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT warsamerahma correctiontrackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT bindermoritz correctiontrackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT kyleroberta correctiontrackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT rajkumarsvincent correctiontrackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab AT kumarshaji correctiontrackingdaratumumabclearanceusingmassspectrometryimplicationsonmproteinmonitoringandreusingdaratumumab |